SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-24-010557
Filing Date
2024-02-06
Accepted
2024-02-06 16:15:16
Documents
1
Group Members
AISLING CAPITAL PARTNERS IV LLCAISLING CAPITAL PARTNERS IV, LPANDREW N. SCHIFFSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea192927-13ga2aisling4_eleva.htm SC 13G/A 87389
  Complete submission text file 0001213900-24-010557.txt   89231
Mailing Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 212-651-6380
Aisling Capital IV, LP (Filed by) CIK: 0001652910 (see all company filings)

IRS No.: 474953768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92657 | Film No.: 24600445
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)